These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25036233)

  • 1. Usefulness of tacrolimus for refractory adult-onset still's disease: Report of six cases.
    Nakamura H; Odani T; Shimizu Y; Takeda T; Kikuchi H
    Mod Rheumatol; 2016 Nov; 26(6):963-967. PubMed ID: 25036233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of a patient with refractory adult Still's disease by tacrolimus.
    Murakami K; Fujii T; Yukawa N; Yoshifuji H; Kawabata D; Tanaka M; Usui T; Mimori T
    Mod Rheumatol; 2007; 17(2):167-70. PubMed ID: 17437176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Adult-Onset Still's Disease Treated with Monitoring of Serum Tacrolimus Levels.
    Ohe M; Bohgaki T
    Bull Hosp Jt Dis (2013); 2015 Jul; 73(3):213-6. PubMed ID: 26535602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid-sparing effects of etanercept in a patient with steroid-dependent adult-onset Still's disease.
    Kiyonaga Y; Maeshima K; Imada C; Haranaka M; Ishii K; Shibata H
    Intern Med; 2014; 53(11):1209-13. PubMed ID: 24881751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult-onset Still's disease in a patient over 80 years old successfully treated with low-dose methotrexate therapy.
    Kurasawa M; Kotani K; Kurasawa G; Shida K; Yamada S; Tago T
    Age Ageing; 2007 Jan; 36(1):104-6. PubMed ID: 17158115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of glucocorticoid and cyclosporine refractory adult-onset Still's disease complicated with hemophagocytic syndrome with plasma exchange therapy and tocilizumab : a case report.
    Komiya Y; Takenaka K; Nagasaka K
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(6):478-83. PubMed ID: 24390109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Infliximab (anti-TNF-alpha) treatment in patients with adult Still's disease. Experience in 2 cases].
    Bonilla Hernán MG; Cobo Ibáñez T; de Miguel Mendieta E; Martín-Mola E
    An Med Interna; 2004 Jan; 21(1):23-6. PubMed ID: 15195482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine.
    Ichikawa T; Shimojima Y; Otuki T; Ueno KI; Kishida D; Sekijima Y
    Intern Med; 2019 Dec; 58(23):3473-3478. PubMed ID: 31391399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of tocilizumab therapy in Korean patients with adult-onset Still's disease: a multicentre retrospective study of 22 cases.
    Song ST; Kim JJ; Lee S; Kim HA; Lee EY; Shin KC; Lee JH; Lee KH; Choi ST; Cha HS; Yoo DH
    Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S64-S71. PubMed ID: 27462914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with tacrolimus of refractory adult-onset Still's disease.
    Ohe M; Oku K; Kono M; Bohgaki T
    Korean J Intern Med; 2014 Mar; 29(2):259-61. PubMed ID: 24648814
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclosporin A in the treatment of adult onset Still's disease.
    Marchesoni A; Ceravolo GP; Battafarano N; Rossetti A; Tosi S; Fantini F
    J Rheumatol; 1997 Aug; 24(8):1582-7. PubMed ID: 9263155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of methotrexate in adult-onset Still's disease.
    Manger B; Rech J; Schett G
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S168-71. PubMed ID: 21044454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients.
    Kokkinos A; Iliopoulos A; Greka P; Efthymiou A; Katsilambros N; Sfikakis PP
    Clin Rheumatol; 2004 Feb; 23(1):45-9. PubMed ID: 14749983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate treatment in patients with adult onset Still's disease--retrospective study of 13 Japanese cases.
    Fujii T; Akizuki M; Kameda H; Matsumura M; Hirakata M; Yoshida T; Shinozawa T; Mimori T
    Ann Rheum Dis; 1997 Feb; 56(2):144-8. PubMed ID: 9068291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
    Ruscitti P; Cipriani P; Liakouli V; Iacono D; Pantano I; Caso F; Perosa F; Atzeni F; Cantatore FP; Scarpa R; Ciccia F; Giacomelli R
    Rheumatol Int; 2020 Jan; 40(1):107-113. PubMed ID: 31263993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anakinra in refractory adult onset Still's disease].
    Vercoutere W; Starmans-Kool M; Peeters RM
    Ned Tijdschr Geneeskd; 2011; 155(18):A2966. PubMed ID: 21466723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult-onset Still's disease: Advances in the treatment.
    Castañeda S; Blanco R; González-Gay MA
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):222-238. PubMed ID: 27886796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory adult-onset still disease successfully treated with abatacept.
    Ostrowski RA; Tehrani R; Kadanoff R
    J Clin Rheumatol; 2011 Sep; 17(6):315-7. PubMed ID: 21869709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.
    Sfriso P; Bindoli S; Galozzi P
    Drugs; 2018 Aug; 78(12):1187-1195. PubMed ID: 30069732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked effect and steroid-sparing ability of anakinra on a patient with refractory adult-onset Still's disease.
    Tamaki H; Shimizu H; Hiraoka E; Uechi E; Kishimoto M; Yamaguchi K; Okada M
    Mod Rheumatol; 2010 Apr; 20(2):200-4. PubMed ID: 20037747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.